Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Sponsor: EMS
Summary
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
Official title: National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
480
Start Date
2024-10-08
Completion Date
2027-09
Last Updated
2025-12-08
Healthy Volunteers
No
Conditions
Interventions
PIEMONTE
Piemonte association 1 coated tablet once a day
PIEMONTE PLACEBO
Placebo of Piemonte association 1 coated tablet once a day
EMPAGLIFLOZIN
Empagliflozin 25 mg 1 coated tablet once a day
PLACEBO EMPAGLIFLOZIN
Placebo of empagliflozin 25 mg 1 coated tablet once a day
PIOGLITAZONE
Pioglitazone 30 mg 1 tablet once a day
PLACEBO PIOGLITAZONE
Placebo of pioglitazone 30 mg 1 tablet once a day
Locations (1)
EMS
Hortolândia, São Paulo, Brazil